Perhydro-1,3,5-trinitro-1,3,5-triazine

Genetic toxicity: in vivo

Administrative data

Endpoint:

in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus

Remarks:

Type of genotoxicity: chromosome aberration

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: It is a GLP study following international guidelines and has been published in a peer reviewed journal.

Data source

Reference

Reference Type:

publication

Title:

Unnamed

Year:

2005

Report date:

2005

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)

GLP compliance:

yes

Type of assay:

micronucleus assay

Test material

Test material information

Constituent 1

Reference substance name:

Perhydro-1,3,5-trinitro-1,3,5-triazine

EC Number:

204-500-1

EC Name:

Perhydro-1,3,5-trinitro-1,3,5-triazine

Cas Number:

121-82-4

Molecular formula:

C3H6N6O6

IUPAC Name:

1,3,5-trinitro-1,3,5-triazinane

Test animals

Species:

mouse

Strain:

CD-1

Sex:

male

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: well known breeder
- Age at study initiation:
- Weight at study initiation:
- Assigned to test groups randomly: [no/yes, under following basis: ]
- Fasting period before study:
- Housing:
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C):18-26°C
- Humidity (%):30% to 70%
- Photoperiod (hrs dark / hrs light):12hrs dark /12 hrs light

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

- Vehicle(s)/solvent(s) used: corn oil
- Concentration of test material in vehicle:
- Amount of vehicle (if gavage or dermal): 10ml/kg
- Lot/batch no. (if required):lot no. 12-394

Details on exposure:

PREPARATION OF DOSING SOLUTIONS:
Test article wasdissolved in corn oil

Duration of treatment / exposure:

24h and 48h

Frequency of treatment:

single dose

Doses / concentrations

Doses / concentrations 1

Remarks:

Doses / Concentrations:
62.5 mg/kg
Basis:
actual ingested

Doses / concentrations 2

Remarks:

Doses / Concentrations:
125 mg/kg
Basis:
actual ingested

Doses / concentrations 3

Remarks:

Doses / Concentrations:
250 mg/kg
Basis:
actual ingested

No. of animals per sex per dose:

5 males/dose for the negative and positive control and the 62.5 and 125 mg/kg and 10/sex/dose for the 250 mg/kg

Control animals:

yes, concurrent vehicle

Positive control(s):

cyclophosphamide in sterile deionized water
- Route of administration: gavage
- Doses / concentrations: 80mg/kg

Examinations

Tissues and cell types examined:

Bone marrow. micronuclei in polychromatic erythrocytes (PCEs) and norchromatic erythrocytes (NCEs)

Details of tissue and slide preparation:

CRITERIA FOR DOSE SELECTION:Based upon the result of the dose range-finding study, the estimated maximum tolerated doses was 250 mglkg after one oral gavage administration

SAMPLING TIMES ( in addition to information in specific fields): 24h and 48h

DETAILS OF SLIDE PREPARATION:Bone marrow smears were prepared and allowed to air dry. The slides were then fixed in methanol, stained in May-Grunwald-Giemsa stain and protected by permanently mounted cover slips.

METHOD OF ANALYSIS:The slides were blind scored for micronuclei in polychromatic erythrocytes (PCEs) and norchromatic erythrocytes (NCEs) and determination of PCE/NCE ratios to access possible bone marrow cytotoxicity.
The micronucleus frequency (expressed as percent micronucleated cell) wasdetennlned by analyzing number of micronucleated PCEs from at least 2000 PCEs per animal. The PCE:NCE ratio was determined by scoring the number of PCEs and NCEs observed while scoring at least the first 500 erythrocytes per animal.

Evaluation criteria:

The criteria for the identification of micronuclei were those of Schmid (1976).

Statistics:

Yes but no details

Results and discussion

Test results

Sex:

male

Genotoxicity:

negative

Remarks:

(no significant decreases in the PCE:NCE ratios observed at any RDX dose or bone marrow sampling time point)

Toxicity:

no effects

Remarks:

no effects RDX at doses 62.5, 125, and 250 mg/kg were not cytotoxic to bone marrow (i.e.no statistically significant decrease in PCE:NCE ratios)

Vehicle controls validity:

valid

Negative controls validity:

not specified

Positive controls validity:

valid

Additional information on results:

RESULTS OF RANGE-FINDING STUDY
- Dose range: up to 500 mg/kg
- Clinical signs of toxicity in test animals: Mice dosed at all dose levels showed neurotoxic signs (hyperactive) and deaths at high dose of 500 mg/kg.

Any other information on results incl. tables

Summary data from micronuleus assay for RDX in bone marrow of CD-l mouse  Treatment  Dose  Harvest time  % Micronucleated PCE (mean of 2000 per animal ±SE)  Ratio PCE:NCE (mean ± S.E.)         Positive control   CP 80 mg/kg  24h   2.39 ± 0.31*  0.57 ± 0.05   Test article   62.5 mg/kg  24h 0.04 ± 0.02 0.47 ± 0.07      125 mg/kg  24h  0.03 ± 0.01  0.36 ± 0.04     250 mg/kg 24  0.02 ± 0.01  0.60 ± 0.05      48h  0.10 ± 0.02  0.69 ± 0.11    Vehicle control   Corn oil 24h    0.05 ± 0.02    0.50 ± 0.07      48h    0.08 ± 0.03   0.71 ± 0.06 *Significantly greater than the corresponding vehicle control,P =0.01 CP = cyclophosphamide. PCE = polychromatic erythrocyte. NCE = normochromatic erythrocyte.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information): negative
RDX was found to be negative in the in vivo mouse bone marrow micronucleus assay.